Related Experiment Video

Updated: Jun 6, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Pneumocystis jirovecii and cystic fibrosis

Enrique J Calderón1, Vicente Friaza, Francisco J Dapena

  • 1Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, CIBER de Epidemiología y Salud Pública, Seville, Spain. ecalderon@ibis-sevilla.es

Medical Mycology
|November 12, 2010
PubMed

Insights

Pneumocystis jirovecii colonization is common in cystic fibrosis patients but does not typically lead to pneumonia. Further research is needed to understand its role in cystic fibrosis progression and transmission.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Pulmonology

Background:

  • Pneumocystis jirovecii is an opportunistic fungus causing pneumonia in immunocompromised individuals.
  • Pneumocystis colonization, detected via molecular methods, occurs in individuals without pneumonia.
  • Colonization prevalence in cystic fibrosis patients varies (1.3-21.6%), with limited longitudinal data.

Purpose of the Study:

  • To investigate the prevalence and clinical significance of Pneumocystis jirovecii colonization in cystic fibrosis patients.
  • To understand the evolution of P. jirovecii colonization in this patient group.
  • To assess the potential role of cystic fibrosis patients as reservoirs for P. jirovecii.

Main Methods:

  • Longitudinal study design.
  • Molecular detection techniques for P. jirovecii.
  • Clinical monitoring of patients for pneumonia development.

Main Results:

  • Pneumocystis jirovecii colonization was observed in cystic fibrosis patients.
  • None of the colonized patients developed P. jirovecii pneumonia during a 1-year follow-up.
  • The long-term evolution and clinical impact of colonization remain largely uncharacterized.

Conclusions:

  • Pneumocystis jirovecii colonization may be prevalent in cystic fibrosis patients without causing immediate pneumonia.
  • Further research is essential to determine the scope of P. jirovecii colonization and its impact on cystic fibrosis.
  • Understanding this role is crucial for developing preventive strategies and improving clinical management.

More Related Videos

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients07:25

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

Published on: July 16, 2020

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections06:57

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections

Published on: May 8, 2017

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation